Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?

被引：0
|
作者：
Eric Van Cutsem
机构：
[1] Professor of Medicine and Head of the Digestive Oncology Unit at the University Hospital Gasthuisberg,
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2004年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：72 / 73
页数：1
相关论文
共 50 条
  • [31] Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review)
    Shao, Chiyun
    Han, Yanjie
    Huang, Yuying
    Zhang, Zhe
    Gong, Tao
    Zhang, Yajie
    Tian, Xiaokang
    Fang, Mingzhi
    Han, Xuan
    Li, Min
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 64 (02)
  • [32] Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
    Ligia Traldi Macedo
    Andre Bacellar da Costa Lima
    Andre Deeke Sasse
    BMC Cancer, 12
  • [33] Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
    Macedo, Ligia Traldi
    da Costa Lima, Andre Bacellar
    Sasse, Andre Deeke
    BMC CANCER, 2012, 12
  • [34] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [35] BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER - THE MCGILL EXPERIENCE
    Wasserman, D. W.
    Bouganim, N.
    Batist, G.
    Ferrario, C.
    Kavan, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 217 - 217
  • [36] Is bevacizumab effective and safe in combination with chemotherapy in patients with colorectal cancer?
    Hope E Uronis
    Herbert I Hurwitz
    Nature Clinical Practice Oncology, 2007, 4 : 214 - 215
  • [37] Is bevacizumab effective and safe in combination with chemotherapy in patients with colorectal cancer?
    Uronis, H. E.
    Hurwitz, H. I.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (04): : 214 - 215
  • [38] EFFICACY AND SAFETY OF BEVACIZUMAB-CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER
    Bensalem, A.
    Ayadi, L.
    Benlakhlef, L.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 114 - 114
  • [39] A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
    Hecht, J. Randolph
    Mitchell, Edith
    Chidiac, Tarek
    Scroggin, Carroll
    Hagenstad, Christopher
    Spigel, David
    Marshall, John
    Cohn, Allen
    McCollum, David
    Stella, Philip
    Deeter, Robert
    Shahin, Seta
    Amado, Rafael G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 672 - 680
  • [40] Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer
    Cazeneuve, Nicolas
    Bouche, Olivier
    Leger, Julie
    Borg, Christophe
    Labbe-Devilliers, Catherine
    Lucidarme, Olivier
    Tasu, Jean-Pierre
    Manfredi, Sylvain
    Aube, Christophe
    Trillaud, Herve
    Manzoni, Philippe
    Marcus, Claude
    Terrebonne, Eric
    Douillard, Jean -Yves
    Chautard, Romain
    Lobet, Sarah
    Bleuzen, Aurore
    Lecomte, Thierry
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
12345